statistiche ricercatore

Continente	#
NA - Nord America	879
EU - Europa	803
AS - Asia	538
SA - Sud America	60
Continente sconosciuto - Info sul continente non disponibili	36
AF - Africa	22
Totale	2.338

Nazione	#
US - Stati Uniti d'America	843
RU - Federazione Russa	216
IT - Italia	211
SG - Singapore	132
CN - Cina	120
VN - Vietnam	108
GB - Regno Unito	81
IE - Irlanda	73
DE - Germania	49
HK - Hong Kong	49
FR - Francia	47
BR - Brasile	46
IN - India	29
SE - Svezia	27
FI - Finlandia	24
BD - Bangladesh	23
KR - Corea	22
CA - Canada	14
ES - Italia	11
MX - Messico	11
NL - Olanda	11
UA - Ucraina	11
IQ - Iraq	10
JP - Giappone	10
PL - Polonia	10
ZA - Sudafrica	10
RS - Serbia	8
CZ - Repubblica Ceca	4
PK - Pakistan	4
PY - Paraguay	4
VE - Venezuela	4
AR - Argentina	3
CH - Svizzera	3
EG - Egitto	3
GR - Grecia	3
IR - Iran	3
JM - Giamaica	3
JO - Giordania	3
KE - Kenya	3
MY - Malesia	3
TR - Turchia	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
BE - Belgio	2
CI - Costa d'Avorio	2
CR - Costa Rica	2
CY - Cipro	2
LK - Sri Lanka	2
PR - Porto Rico	2
PT - Portogallo	2
AM - Armenia	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BN - Brunei Darussalam	1
BY - Bielorussia	1
CL - Cile	1
CO - Colombia	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GT - Guatemala	1
HU - Ungheria	1
IS - Islanda	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
MK - Macedonia	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
PH - Filippine	1
SA - Arabia Saudita	1
SC - Seychelles	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UG - Uganda	1
Totale	2.302

Nome	#
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients	331
Biomarkers in COVID-19 pandemic: implications for acute phase assessment and chronic management	283
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?	277
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19	241
Non-neoplastic asbestos-related respiratory diseases: what relationship with other lung diseases?	226
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female	223
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases	208
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis	204
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae	164
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis	106
Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6	75
Totale	2.338

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	64	0	0	0	2	3	1	7	6	5	12	13	15
2022/2023	143	6	19	20	24	7	24	8	15	11	6	0	3
2023/2024	193	9	1	8	8	6	39	38	8	11	25	8	32
2024/2025	463	28	28	49	26	47	31	49	26	32	29	37	81
2025/2026	1.079	66	118	103	138	191	35	171	27	34	67	60	69
2026/2027	147	34	22	36	55	0	0	0	0	0	0	0	0
Totale													2.338